As of the latest SEC filings, BeOne Medicines Ltd. (ONC) is held by 268 institutional funds. The largest fund shareholder is New Perspective Fund (ANWPX), holding an estimated $791,116,201.20 in market value, representing 0.52% of its portfolio.
Funds holding BeOne Medicines Ltd. (ONC)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- ONC
- CIK:
- 0001651308
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
ANWPX
New Perspective Fund
|
MF | Independent / Boutique | 0.52% | $791,116,201.20 | 2,663,960 | Mar 31, 2026 | May 28, 2026 |
|
VPMAX
VANGUARD PRIMECAP FUND
|
MF | Vanguard | 0.95% | $688,858,145.34 | 2,319,622 | Mar 31, 2026 | May 28, 2026 |
|
VHCAX
VANGUARD CAPITAL OPPORTUNITY FUND
|
MF | Vanguard | 1.41% | $347,327,499.87 | 1,169,571 | Mar 31, 2026 | May 28, 2026 |
|
VTISX
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
|
ETF | Vanguard | 0.04% | $261,552,719.77 | 11,522,568 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMIX
VANGUARD EMERGING MARKETS STOCK INDEX FUND
|
ETF | Vanguard | 0.15% | $247,602,536.80 | 10,908,000 | Apr 30, 2026 | Jun 26, 2026 |
|
FCNTX
Fidelity Contrafund
|
MF | Fidelity | 0.14% | $218,360,556.15 | 735,295 | Mar 31, 2026 | May 26, 2026 |
|
CEUAX
EUPAC Fund
|
MF | Independent / Boutique | 0.17% | $216,902,730.42 | 730,386 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.24% | $198,085,783.04 | 624,896 | Feb 28, 2026 | Apr 24, 2026 |
|
POAGX
PRIMECAP Odyssey Aggressive Growth Fund
|
MF | Independent / Boutique | 2.88% | $195,160,773.39 | 660,957 | Apr 30, 2026 | Jun 29, 2026 |
|
POGRX
PRIMECAP Odyssey Growth Fund
|
MF | Independent / Boutique | 3.20% | $173,544,056.69 | 587,747 | Apr 30, 2026 | Jun 29, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 1.93% | $157,139,596.71 | 529,143 | Mar 31, 2026 | May 28, 2026 |
|
CNWAX
New World Fund Inc
|
MF | Independent / Boutique | 0.18% | $154,511,838.30 | 523,290 | Apr 30, 2026 | Jun 26, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 1.19% | $129,161,256.95 | 5,757,796 | Mar 31, 2026 | May 28, 2026 |
|
CGVYX
American Funds Global Insight Fund
|
MF | Capital Group / American Funds | 0.54% | $110,433,046.89 | 374,007 | Apr 30, 2026 | Jun 26, 2026 |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
ETF | First Trust | 3.12% | $70,878,423.84 | 238,672 | Mar 31, 2026 | May 28, 2026 |
|
PAITX
T. Rowe Price International Stock Fund
|
MF | T. Rowe Price | 0.51% | $70,802,498.03 | 239,789 | Apr 30, 2026 | Jun 25, 2026 |
|
ANWPX
New Perspective Fund
|
MF | Independent / Boutique | 0.04% | $65,092,611.78 | 2,871,700 | Mar 31, 2026 | May 28, 2026 |
|
CCWIX
Baird Chautauqua International Growth Fund
|
MF | Independent / Boutique | 4.29% | $61,573,759.80 | 207,340 | Mar 31, 2026 | May 15, 2026 |
|
MCHI
iShares MSCI China ETF
|
ETF | BlackRock / iShares | 0.76% | $56,516,281.11 | 2,289,370 | Feb 28, 2026 | Apr 23, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.24% | $56,151,608.60 | 177,140 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.23% | $49,240,909.61 | 155,339 | Feb 28, 2026 | Apr 24, 2026 |
|
SEMNX
Hartford Schroders Emerging Markets Equity Fund
|
MF | Independent / Boutique | 0.64% | $48,483,150.38 | 2,135,900 | Apr 30, 2026 | Jun 25, 2026 |
|
FLCNX
Fidelity Contrafund K6
|
MF | Fidelity | 0.14% | $47,187,048.15 | 158,895 | Mar 31, 2026 | May 26, 2026 |
|
FKDNX
Franklin Dynatech Fund
|
MF | Franklin Templeton | 0.18% | $44,545,500.00 | 150,000 | Mar 31, 2026 | May 27, 2026 |
|
PIEJX
Global Emerging Markets Fund
|
MF | Independent / Boutique | 0.57% | $44,177,122.91 | 1,946,200 | Apr 30, 2026 | Jun 25, 2026 |
Advertisement (320x50)